In this issue of Current Oncology
2007
Current Oncology Issue Overview
Editorial
Author Information
Author(s): McLean M. MD
Conclusion
Advances in management have led to a demonstrable improvement in survival for ovarian cancer patients initially treated with surgery.
Supporting Evidence
- Age-standardized incidence and mortality rates for ovarian cancer have remained stable.
- New drug combinations for myeloma are being explored after nearly 40 years of standard treatment.
- HGF and its receptor may be potential therapeutic targets for cancer treatment.
- CEACAM5 and CEACAM6 may represent targets for novel cancer therapies.
Takeaway
This issue of Current Oncology talks about new findings in cancer treatment and the history of oncology, showing that some treatments are getting better.
Want to read the original?
Access the complete publication on the publisher's website